Big pharmaceutical companies’ CEOs visits to Korea are glad, yet not big deals

In this year, decision makers of global pharmaceutical companies, such as presidents and CEOs, have visited Korea in a series.

They all are from well-known pharmaceutical companies, such as Lilly, Beohringer Ingelheim, AstraZeneca and Johnson & Johnson, and it has only been 4 months since the New Year started. There are also more than 10 upcoming multinational pharmaceutical companies which w...